返回
Sunshine Lake Pharma Co., Ltd.（06887.HK）价格
06887.HK 股价走势图
SUNSHINE PHARMA (06887.HK)
Sunshine Lake Pharma Co., Ltd.
暂无数据Earnings FAQ
06887.HK 最近的每股收益与预期相比如何？
Sunshine Lake Pharma Co., Ltd. 06887.HK 上一季度的收入表现如何？
Sunshine Lake Pharma Co., Ltd. 的收入预期是多少？
Sunshine Lake Pharma Co., Ltd. 的盈利质量评分是多少？
Sunshine Lake Pharma Co., Ltd. 何时发布财报？
Sunshine Lake Pharma Co., Ltd. 的预期收益是多少？
Sunshine Lake Pharma Co., Ltd. 是否超出收益预期？
关键数据
前收盘价
$43.38
开盘价
$43.38
当日区间
$42.9 - $43.62
52周范围
$40.54 - $62.3
交易量
14.5K
平均成交量
394.4K
每股收益（TTM）
-0.35
股息收益率
--
市值
$4.8B
什么是 SUNSHINE PHARMA？
Sunshine Lake Pharma Co., Ltd. operates as a pharmaceutical company. The company is headquartered in Dongguan, Guangdong and currently employs 6,533 full-time employees. The company went IPO on 2025-08-07. The firm focuses on innovative drugs and is also involved in modified new drugs, generic drugs and biosimilars. The Company’s anti-infective products include Kewei (oseltamivir phosphate), for the treatment of influenza (in particular, Type A and Type B influenza viruses), Dongweien (emitasvir phosphate), for the treatment of hepatitis C, and generic drugs for the treatment of infections caused by sensitive bacteria, namely Clarithromycin, Levofloxacin and Moxifloxacin Hydrochloride. The Company’s commercialized chronic disease treatment drugs primarily focus on the treatment of diabetes, hyperuricemia, hypertension and stomach acid related disease, including insulin products and generic drugs. The firm also focuses on therapeutic area of oncology.